Generation and efficacy evaluation of a recombinant pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs

Clinical and Vaccine Immunology

Volumn 22, Issue 10, 2015, Pages 1121-1129

  Wang, Yimin ^a   Yuan, Jin ^a   Cong, Xin ^a   Qin, Hua Yang ^a   Wang, Chun Hua ^a   Li, Yongfeng ^a   Li, Su ^a   Luo, Yuzi ^a   Sun, Yuan ^a   Qiu, Hua Ji ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

E2 PROTEIN; NEUTRALIZING ANTIBODY; PSEUDORABIES VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CLASSICAL SWINE FEVER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; E2 GENE; GENE EXPRESSION; IMMUNOGENICITY; INFECTION PREVENTION; INFECTION RESISTANCE; MIXED INFECTION; NONHUMAN; PIG; PRIORITY JOURNAL; PSEUDORABIES; VIRUS GENE; VIRUS RECOMBINANT; ANIMAL; BLOOD; CHINA; CLASSICAL SWINE FEVER VIRUS; COINFECTION; EVALUATION STUDY; GENETICS; IMMUNOLOGY; PSEUDORABIES VIRUS; SWINE DISEASES; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHINA; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; COINFECTION; HERPESVIRUS 1, SUID; PSEUDORABIES; PSEUDORABIES VACCINES; SWINE; SWINE DISEASES; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84943265714     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00383-15     Document Type: Article

References (27)

1. Moennig V, Floegel-Niesmann G, Greiser-Wilke I. 2003. Clinical signs and epidemiology of classical swine fever: a review of new knowledge. Vet J 165:11-20. http://dx.doi.org/10.1016/S1090-0233(02)00112-0.
2. de Smit AJ, van Gennip HG, Miedema GK, van Rijn PA, Terpstra C, Moormann RJ. 2000. Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristics. Vaccine 18:2351-2358. http://dx.doi.org/10.1016/S0264-410X(00)00027-X.
3. Dong XN, Chen YH. 2007. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25:205-230. http://dx.doi.org/10.1016/j.vaccine.2006.07.033.
4. Suradhat S, Intrakamhaeng M, Damrongwatanapokin S. 2001. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet Immunol Immunopathol 83:177-189. http://dx.doi.org/10.1016/S0165-2427(01)00389-0.
5. Mettenleiter TC. 2000. Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis - state of the art, June 1999. Vet Res 31:99-115.
6. Pomeranz LE, Reynolds AE, Hengartner CJ. 2005. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol Mol Biol Rev 69:462-500. http://dx.doi.org/10.1128/MMBR.69.3.462-500.2005.
7. van Zijl M, Wensvoort G, de Kluyver E, Hulst M, van der Gulden H, Gielkens A, Berns A, Moormann R. 1991. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65:2761-2765.
8. Qiu HJ, Tian ZJ, Tong GZ, Zhou YJ, Ni JQ, Luo YZ, Cai XH. 2005. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Vet Immunol Immunopathol 106:309-319. http://dx.doi.org /10.1016/j.vetimm.2005.03.008.
9. Jiang Y, Fang L, Xiao S, Zhang H, Pan Y, Luo R, Li B, Chen H. 2007. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Vaccine 25:547-560. http: //dx.doi.org/10.1016/j.vaccine.2006.07.032.
10. Hong Q, Qian P, Li XM, Yu XL, Chen HC. 2007. A recombinant pseudorabies virus co-expressing capsid proteins precursorP1-2AofFMDVandVP2 protein of porcine parvovirus: a trivalent vaccine candidate. Biotechnol Lett 29:1677-1683. http://dx.doi.org/10.1007/s10529-007-9459-6.
11. He Y, Qian P, Zhang K, Yao Q, Wang D, Xu Z, Wu B, Jin M, Xiao S, Chen H. 2008. Construction and immune response characterization of a recombinant pseudorabies virus co-expressing capsid precursor protein (P1) and a multiepitope peptide of foot-and-mouth disease virus in swine. Virus Genes 36:393-400. http://dx.doi.org/10.1007/s11262-008-0204-6.
12. Li X, Liu R, Tang H, Jin M, Chen H, Qian P. 2008. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Vaccine 26:2714-2722. http://dx.doi.org/10.1016/j.vaccine.2008.03.020.
13. An TQ, Peng JM, Tian ZJ, Zhao HY, Li N, Liu YM, Chen JZ, Leng CL, Sun Y, Chang D, Tong GZ. 2013. Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012. Emerg Infect Dis 19:1749-2755. http: //dx.doi.org/10.3201/eid1911.130177.
14. Wu R, Bai C, Sun J, Chang S, Zhang X. 2013. Emergence of virulent pseudorabies virus infection in northern China. J Vet Sci 14:363-365. http://dx.doi.org/10.4142/jvs.2013.14.3.363.
15. Luo Y, Li N, Cong X, Wang CH, Du M, Li L, Zhao B, Yuan J, Liu DD, Li S, Li Y, Sun Y, Qiu HJ. 2014. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China. Vet Microbiol 174:107-115. http: //dx.doi.org/10.1016/j.vetmic.2014.09.003.
16. Yu X, Zhou Z, Hu D, Zhang Q, Han T, Li X, Gu X, Yuan L, Zhang S, Wang B, Qu P, Liu J, Zhai X, Tian K. 2014. Pathogenic pseudorabies virus, China, 2012. Emerg Infect Dis 20:102-104. http://dx.doi.org/10.3201/eid2001.130531.
17. Wang CH, Yuan J, Qin HY, Luo Y, Cong X, Li Y, Chen J, Li S, Sun Y, Qiu HJ. 2014. A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China. Vaccine 32:3379-3385. http://dx.doi.org/10.1016/j.vaccine.2014.04.035.
18. Sun Y, Liu DF, Wang YF, Liang BB, Cheng D, Li N, Qi QF, Zhu QH, Qiu HJ. 2010. Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus. Res Vet Sci 88:77-82. http://dx.doi.org/10.1016/j.rvsc.2009.06.005.
19. Peng WP, Hou Q, Xia ZH, Chen D, Li N, Sun Y, Qiu HJ. 2008. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of classical swine fever virus by phage-displayed random peptide library. Virus Res 135:267-272. http://dx.doi.org/10.1016/j.virusres.2008.04.003.
20. Mettenleiter TC. 1989. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171:623-625. http://dx.doi.org/10.1016/0042-6822(89)90635-1.
21. Zhao JJ, Cheng D, Li N, Sun Y, Shi Z, Zhu QH, Tu C, Tong GZ, Qiu HJ. 2008. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and C-strain vaccine of classical swine fever virus. Vet Microbiol 126:1-10. http://dx.doi.org/10.1016/j.vetmic.2007.04.046.
22. Peeters B, Bienkowska-Szewczyk K, Hulst M, Gielkens A, Kimman T. 1997. Biologically safe, non-transmissible pseudorabies virus vector vaccine protects pigs against both Aujeszky's disease and classical swine fever. J Gen Virol 78:3311-3315.
23. Cao SJ, Wen XT. 2004. Studies on the detection of PRV antibody using Dot-PPA-ELISA in pig serum. Chin J Prev Vet Med 26:213-215. (In Chinese.)
24. Sun Y, Li HY, Tian DY, Han QY, Zhang X, Li N, Qiu HJ. 2011. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Vaccine 29:8364-8372. http://dx.doi.org/10.1016/j.vaccine.2011.08.085.
25. Li N, Qiu HJ, Zhao JJ, Li Y, Wang MJ, Lu BW, Han CG, Hou Q, Wang ZH, Gao H, Peng WP, Li GX, Zhu QH, Tong GZ. 2007. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Vaccine 25:2907-2912. http://dx.doi.org/10.1016/j.vaccine.2006.08.020.
26. Yu X, Tu C, Li H, Hu R, Chen C, Li Z, Zhang M, Yin Z. 2001. DNA-mediated protection against classical swine fever virus. Vaccine 19: 1520-1525. http://dx.doi.org/10.1016/S0264-410X(00)00334-0.
27. Leifer I, Lange E, Reimann I, Blome S, Juanola S, Duran JP, Beer M. 2009. Modified live marker vaccine candidate CP7-E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization. Vaccine 27: 6522-6529. http://dx.doi.org/10.1016/j.vaccine.2009.08.057.